Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
National CineMedia
NCMI
$252M
| $7.79M | ﹤0.01% |
2,003,352
+463,112
| +30% | +$1.92M |
|
1877
CG Oncology
CGON
$6.62B
| $7.79M | ﹤0.01% |
187,510
+33,555
| +22% | +$1.39M |
|
1878
Sunrun
RUN
$2.37B
| $7.77M | ﹤0.01% |
422,204
-2,281,066
| -84% | -$43.7M |
|
1879
PUT
VanEck Oil Services ETF
OIH
$1.95B
| $7.75M | ﹤0.01% |
27,200
| – | – |
|
1880
CALL
XPeng
XPEV
$11.3B
| $7.73M | ﹤0.01% |
381,300
+281,300
| +281% | +$6.1M |
|
1881
PUT
Hubbell
HUBB
$26.8B
| $7.73M | ﹤0.01% |
+17,400
| New | +$7.62M |
|
|
VSXY
1882
Victoria's Secret
VSXY
$7.24B
| $7.71M | ﹤0.01% |
142,338
+2,893
| +2% | +$115K |
|
1883
Hyatt Hotels
H
$16.9B
| $7.71M | ﹤0.01% |
48,088
-387,355
| -89% | -$59.3M |
|
|
NTST
1884
NETSTREIT Corp
NTST
$2.09B
| $7.67M | ﹤0.01% |
434,988
+26,897
| +7% | +$490K |
|
1885
Samsara
IOT
$24B
| $7.66M | ﹤0.01% |
216,149
-15,203
| -7% | -$588K |
|
|
PMT
1886
PennyMac Mortgage Investment
PMT
$828M
| $7.6M | ﹤0.01% |
605,880
-386,701
| -39% | -$4.82M |
|
1887
Viridian Therapeutics
VRDN
$2.49B
| $7.6M | ﹤0.01% |
244,273
+36,027
| +17% | +$988K |
|
1888
RadNet
RDNT
$6.08B
| $7.6M | ﹤0.01% |
106,497
+9,955
| +10% | +$769K |
|
|
MASI
1889
DELISTED
Masimo
MASI
| $7.59M | ﹤0.01% |
58,358
-19,446
| -25% | -$2.78M |
|
1890
Riot Platforms
RIOT
$7.21B
| $7.57M | ﹤0.01% |
597,775
-531,794
| -47% | -$9.1M |
|
1891
Impinj
PI
$5.46B
| $7.57M | ﹤0.01% |
43,502
+5,592
| +15% | +$996K |
|
1892
CALL
Lam Research
LRCX
$422B
| $7.57M | ﹤0.01% |
44,200
-80,000
| -64% | -$12.4M |
|
|
FYBR
1893
DELISTED
Frontier Communications
FYBR
| $7.54M | ﹤0.01% |
197,987
-40,613
| -17% | -$1.53M |
|
1894
Banc of California
BANC
$3.11B
| $7.54M | ﹤0.01% |
390,622
+184,229
| +89% | +$3.3M |
|
|
ONC
1895
BeOne Medicines Ltd
ONC
$40.3B
| $7.53M | ﹤0.01% |
24,801
+11,393
| +85% | +$3.73M |
|
1896
Brookfield Asset Management
BAM
$89.2B
| $7.53M | ﹤0.01% |
143,789
+133,366
| +1,280% | +$7.17M |
|
1897
StepStone Group
STEP
$4.28B
| $7.51M | ﹤0.01% |
117,097
+6,085
| +5% | +$385K |
|
1898
CALL
RTX Corp
RTX
$297B
| $7.5M | ﹤0.01% |
40,900
-2,000
| -5% | -$347K |
|
1899
Enpro
NPO
$7.12B
| $7.49M | ﹤0.01% |
34,997
-12,305
| -26% | -$2.72M |
|
|
CSW
1900
CSW Industrials
CSW
$5.59B
| $7.46M | ﹤0.01% |
25,429
+2,006
| +9% | +$535K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.